Skip to main content

CymaBay Therapeutics, Inc.

CBAYDelisted Mar 22, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001042074

CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.

Superinvestors holding CBAY, Q4 2023

See all superinvestors

No superinvestor reported holding CBAY in Q4 2023.